Biomanufacturing technologies — taking modified versions of existing organisms and bending them to the will of humans — has moved from the world of science fiction to becoming a new reality. Across the startup landscape companies are launching to make synthetic spider silk, or make leather substitutes, or meat substitutes, or novel chemicals and pharmaceuticals. […]
View More Two former members of Google’s skunkworks division have launched a biomanufacturing companyCategory: pharmaceuticals
Johnson & Johnson reportedly knew for decades about asbestos in baby powder products
A report from Reuters claims that Johnson & Johnson apparently knew that there were asbestos — or microscopic fibers that can cause cancer — in its baby powder products
Earlier this year, J&J were ordered by a judge to pay over $4 billion in damages to 22 women and their families. Read more…
More about Mashable Video, Cancer, Johnson Johnson, Pharmaceuticals, and Asbestos
View More Johnson & Johnson reportedly knew for decades about asbestos in baby powder productsWeed in space is going to be a thing now
Scientists interested in cannabis as a subject for pharmaceutical studies may find an unlikely new home for their research into the plant, its byproducts and biochemistry aboard the International Space Station. Yes, weed is going to space thanks to the work of a small Lexington, Ky.-based startup called Space Tango. The company makes a “clean […]
View More Weed in space is going to be a thing nowAs biological manufacturing moves to the mainstream, Synvitrobio rebrands and raises cash
The pace at which the scientific breakthroughs working to bend the machinery of life to the whims of manufacturing have transformed into real businesses has intensified competition in the biomanufacturing market. That’s just one reason why Synvitrobio is rebranding as it takes on $2.6 million in new financing to pursue opportunities in biopharmaceutical and biochemical manufacturing. […]
View More As biological manufacturing moves to the mainstream, Synvitrobio rebrands and raises cashHome DNA test results from 23andMe to help develop drugs
Pharmaceutical giant GlaxoSmithKline has invested $300 million into home DNA testing company 23andMe, allowing it to develop drugs based on human genetics.
The four-year agreement allows GSK access to 23andMe’s vast database to accelerate its drug re…
Reverie Labs uses new machine learning algorithms to fix drug development bottlenecks
Developing new medicines can take years of research and cost millions of dollars before they are even ready for clinical trials. Several biotech startups are using machine learning to revolutionize the process and get drugs into pharmacies more quickly. One of the newest is called Reverie Labs, which is part of Y Combinator’s latest batch. […]
View More Reverie Labs uses new machine learning algorithms to fix drug development bottlenecks